[1]. Relationship Between Adverse Events and Progression-free Survival in Patients Receiving Cabozantinib for Previously Treated Metastatic Renal Cell Carcinoma.
Anticancer research [巻]44 [号]2 [頁]781 -786 （2024年） [査読] 有
[DOI] [2]. Preoperative factors predicting poor therapeutic efficacy of holmium laser enucleation of the prostate in patients with benign prostatic hyperplasia
LUTS-LOWER URINARY TRACT SYMPTOMS [巻]16 [号]4 （2024年） [査読] 有
[DOI] [3]. New horizon of lower urinary tract function revealed by molecular biology 脊髄損傷マウスにおけるKCC2クロライドイオン・トランスポーターのダウンレギュレーションは排尿筋過活動と関連する(Downregulation of KCC2 chloride ion transporter in mice with spinal cord injury is associated with detrusor overactivity)
日本泌尿器科学会総会 (一社)日本泌尿器科学会総会事務局 [巻]111回 [頁]SY37 -SY37-4 （2024年） [査読] 無
[4]. Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
International journal of urology : official journal of the Japanese Urological Association [巻]30 [号]9 [頁]730 -736 （2023年） [査読] 有
[DOI] [5]. Therapeutic effects of KCC2 chloride transporter activation on detrusor overactivity in mice with spinal cord injury.
American journal of physiology. Renal physiology [巻]324 [号]4 [頁]F353 -F361 （2023年） [査読] 有
[DOI]